Colleen Channick is a Respiratory physician affiliated with University of California, Los Angeles. OpenAlex indexes 69 publications with 2,582 citations (h-index 14); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1223 16th St Ste 3400
Santa Monica, CA 904041279
Telephone
310-449-0939Registry record last updated 5 Jul 2019.
Clinical trials
- Pilot Study to Evaluate the Role of EBUS in the Diagnosis of Acute PE in Critically Ill Patients
Sponsor: University of California, Los Angeles
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Noah Medical CorporationProgram year20252 payments
- INTUITIVE SURGICAL, INC.Program year20251 payment
- Merck Sharp & Dohme LLCProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
45.9%Corticosteroid45.9%Prednisone100%Part D≥11 patientsRespiratory
36.5%beta2-Adrenergic Agonist36.5%Albuterol Sulfate Hfa100%Part D≥13 patientsAnti-infectives
17.6%Penicillins with extended spectrum17.6%Amoxicillin-Clavulanate Potass100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- EP.07.14 Contemporary Stereotactic Body Radiation Therapy Utilization Trends for Stage I Non Small Cell Lung Cancer
Journal of Thoracic Oncology
2025 - American Association of Bronchology and Interventional Pulmonology Essential Knowledge in Interventional Pulmonology Series
Journal of Bronchology & Interventional Pulmonology
2025 - Cryoprobe biopsy versus mechanical biopsies in pulmonary diagnostics
Current Opinion in Pulmonary Medicine
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Gregg Fonarow, MD
University of California, Los Angeles
Dennis Slamon, MD
University of California, Los Angeles
Tomas Ganz, MD
University of California, Los Angeles
Richard Casaburi, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”